Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-21-015549
Filing Date
2021-06-29
Accepted
2021-06-29 16:18:15
Documents
1
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 2895
  Complete submission text file 0001493152-21-015549.txt   4395
Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Issuer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 9137 RIDGELINE BOULEVARD, SUITE 135 HIGHLANDS RANCH CO 80129
Business Address
Huntsman Ronald Kirk (Reporting) CIK: 0001835498 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39796 | Film No.: 211058322